Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
Pilot Study Of Valganciclovir In Patients With Classic, Non-HIV-Associated Kaposi's Sarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
A NA clinical study on Sarcoma, this trial is completed. The trial is conducted by Memorial Sloan Kettering Cancer Center and has accumulated 6 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Apr 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- New York Presbyterian Hospital
- University of North Carolina, Chapel Hill
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .